Kantoff Philip W. [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Kantoff Philip W.

Create: Alert

All | News | Filings

Date Filed

Type

Description

05/31/2023

Kantoff Philip W. (Director) has filed a Form 4 on Context Therapeutics Inc.

Txns:

Granted 25,000 options to buy @ $0.87, valued at $21.8k

09/21/2022

Kantoff Philip W. (Director) has filed a Form 3 on ESSA Pharma Inc.

06/03/2022

Form 4 - Statement of changes in beneficial ownership of securities:

10/19/2021

Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy